Global and United States Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2027

The Nicotinamide Mononucleotide (NMN) market covers Content ＜98%, Content ≥98%, etc. The typical players include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, etc. Nicotinamide mononucleotide is a nucleotide derived from ribose and nicotinamide. NMN is made from B vitamins in the body, and is a molecule naturally occurring in all life forms.
The main global Nicotinamide Mononucleotide (NMN) players include GeneHarbor, Herbalmax, Shinkowa Pharmaceutical, EffePharm, etc. The top four Nicotinamide Mononucleotide (NMN) players account for approximately 83% of the total market. Asia-Pacific is the largest consumer market for Nicotinamide Mononucleotide (NMN), accounting for about 76%, followed by Europe and Americas. In terms of type, Content ≥98% is the largest segment, with a share over 99%. And in terms of application, the largest application is Health Care Products, followed by Cosmetics.

The downstream applications of nicotinamide mononucleotide include health care products and cosmetics. Health products are the largest application market. In 2019, health products accounted for 98% of the total downstream consumption of nicotinamide mononucleotide in global.

Market Analysis and Insights: Global and United States Nicotinamide Mononucleotide (NMN) Market
This report focuses on global and United States Nicotinamide Mononucleotide (NMN) market.
In 2020, the global Nicotinamide Mononucleotide (NMN) market size was US$ 209.6 million and it is expected to reach US$ 446.6 million by the end of 2027, with a CAGR of 10.0% during 2021-2027. In United States the Nicotinamide Mononucleotide (NMN) market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Nicotinamide Mononucleotide (NMN) Scope and Market Size
Nicotinamide Mononucleotide (NMN) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nicotinamide Mononucleotide (NMN) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Nicotinamide Mononucleotide (NMN) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Content below 98%
Content above 98%

Segment by Application
Health Care Products
Cosmetics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway